Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions

被引:31
作者
Mulky, A
Sarafianos, SG
Jia, YJ
Arnold, E
Kappes, JC [1 ]
机构
[1] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[2] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[4] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[5] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA
关键词
reverse transcriptase; subunit-specific; Trp-motif; dimerization; NNRTI;
D O I
10.1016/j.jmb.2005.03.057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) functions as a heterodimer (p51/p66), which makes disruption of subunit interactions a possible target for antiviral drug design. Our understanding of subunit interface interactions has been limited by the lack of virus-based approaches for studying the heterodimer. Therefore, we developed a novel subunit-specific mutagenesis approach that enables precise molecular analysis of the heterodimer in the context of infectious HIV-1 particles. Here, we analyzed the contributions of amino acid residues comprising the Trp-motif to RT subunit interaction and function. Our results reveal important inter- and intra-subunit interactions of residues in the Trp-motif. A tryptophan cluster in p51. (W398, W402, W406, W414), proximal to the interface, was found to be important for p51/p66 interaction and stability. At the dimer interface, residues W401, Y405 and N363 in p51 and W410 in p66 mediate inter-subunit interactions. The W401 residue is critical for RT dimerization, exerting distinct effects in p51 and p66. Our analysis of the RT heterodimerization enhancing nonnucleoside RT inhibitor (NNRTI), efavirenz, indicates that the effects of drugs on RT dimer stability can be examined in human cells. Thus, we provide the first description of subunit-specific molecular interactions that affect RT heterodimer function and virus infection in vivo. Moreover, with heightened interest in novel RT inhibitors that affect dimerization, we demonstrate the ability to assess the effects of RT inhibitors on subunit interactions in a physiologically relevant context. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:673 / 684
页数:12
相关论文
共 46 条
  • [31] The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits
    Sevilya, Z
    Loya, S
    Hughes, SH
    Hizi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 311 (05) : 957 - 971
  • [32] Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-{spiro[4"-amino-2",2"-dioxo-1",2"-oxathiole-5",3′-[2′,5′-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]]}-3-ethylthymine
    Sluis-Cremer, N
    Dmitrienko, GI
    Balzarini, J
    Camarasa, MJ
    Parniak, MA
    [J]. BIOCHEMISTRY, 2000, 39 (06) : 1427 - 1433
  • [33] Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors
    Sluis-Cremer, N
    Arion, D
    Parniak, MA
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (02) : 398 - 405
  • [34] Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation
    Tachedjian, G
    Moore, KL
    Goff, SP
    Sluis-Cremer, N
    [J]. FEBS LETTERS, 2005, 579 (02): : 379 - 384
  • [35] Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization
    Tachedjian, G
    Aronson, HEG
    de los Santos, M
    Seehra, J
    McCoy, JM
    Goff, SP
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 326 (02) : 381 - 396
  • [36] Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase
    Tachedjian, G
    Orlova, M
    Sarafianos, SG
    Arnold, E
    Goff, SP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7188 - 7193
  • [37] Telesnitsky A., 1997, P121
  • [38] Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase
    Temiz, NA
    Bahar, I
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2002, 49 (01) : 61 - 70
  • [39] Characterization of an integrase mutant of feline immunodeficiency virus
    Tomonaga, K
    Itagaki, SI
    Kashiwase, H
    Kawaguchi, Y
    Inoshima, Y
    Ikeda, Y
    Mikami, T
    [J]. ARCHIVES OF VIROLOGY, 1998, 143 (01) : 1 - 14
  • [40] Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
    Tuske, S
    Sarafianos, SG
    Clark, AD
    Ding, JP
    Naeger, LK
    White, KL
    Miller, MD
    Gibbs, CS
    Boyer, PL
    Clark, P
    Wang, G
    Gaffney, BL
    Jones, RA
    Jerina, DM
    Hughes, SH
    Arnold, E
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (05) : 469 - 474